Table 1

Thyroid function assessment in patients with CD and controls with TA at study entry

Patients with CD plus TAControls with TA
Patients, % (N)10 (56/558)8.2 (51/622)
Median age (years (range))10.3 (0.8–11.2)9.7 (0.9–11.5)
M/F17/3913/38
Prevalence of positive TPOAb, % (N)84 (47/56)75 (38/51)
Prevalence of positive TgAb, % (N)63 (35/56)51 (26/51)
TSH SD (µIU/ml, (mean±SD))2.7±1.42.9±1.2
fT3 (ng/ml, (mean±SD))3.8±0.43.7±1.2
fT4 (pg/ml, (mean±SD))1.4±1.11.0±0.1
Positive thyroid ultrasound, % (N)41 (23/56)47 (24/51)
Patients starting L-T4, % (N)2 (1/56)6 (3/51)
  • CD, coeliac disease; fT3, free tri-iodothyronine; fT4, free thyroxine; L-T4, L-thyroxine; TA, thyroid autoimmunity; TgAb, antithyroglobulin antibodies; TPOAb, antithyroperoxidase antibodies; TSH, thyroid-stimulating hormone.